The global softgel capsules market size was estimated to be US$ 7.5 billion in 2021 and is expected to grow at a CAGR of 7.5% between 2023 to 2032.
Softgel capsules are a type of capsules that are mainly made from organic consumable substances like gelatin, pullulan, HPMC, potato starch, pectin, etc. Softgel capsules enhance the absorption time of poorly soluble formulations that are present in semi-solid or liquid form.
Softgel capsules provide ease of swallowing, improved bioavailability, non-reactivity, and extended shelf life to the formulation. Due to such obvious benefits, they offer when compared to tablets or other methods of oral formulations, they are being adopted by pharmaceutical companies across the globe.
For several years the softgel capsules have been made from gelatin, however, recent investments made by manufacturers in R&D have developed new materials. Softgel capsules with less reactivity and vegetarian sources have resulted in new usage and acceptance of these types of capsulations in large numbers.
Increased support for the usage of softgel capsules, rising use of softgel capsules in health supplements, rise in consumer acceptance of vegetarian softgel capsules, rising geriatric population, governmental awareness, and expenditure growth, increased e-commerce-based shopping, and established supply lines are together enabling better growth of Softgel Capsules Market across the globe.
The major growth accelerators for the softgel capsules market have been the rapid development of material and manufacturing techniques that are utilized in this sector. Growing research has resulted in substances like hydroxypropyl methylcellulose (HPMC), potato starch, etc being used efficiently in softgel shells boosting overall acceptance and sales in softgel capsules market. New-age manufacturing techniques also offer faster, more economical, and hygienic ways to produce softgel capsules which also boosts production numbers.
The nutraceutical industry is the major user of softgel capsules in their products. Various nutraceutical formulations are better delivered through softgel capsules and are also preferred by consumers. A recent surge in the usage of health supplements due to growing awareness of healthcare, especially after the pandemic has also resulted in the growth of the global softgel capsules market. The above reasons are also expected to help the growth of this industry during the forecast period.
Furthermore, advanced research activities aimed at creating empty softgel shells for versatile and convenient delivery of nutraceutical, cosmeceutical, and pharmaceutical formulations will diversify the usability and thus promote the softgel capsules market.
Nutraceutical and cosmeceuticals companies are more likely to favor empty shells which can be used for diverse formulations in liquid or semi-solid form owing to their vast portfolio of chemical constituents. Softgel capsules with enhanced features like chew caps, duocaps, hydrophilic sandwich capsules, etc, are also seeing extensive demand and usage. Due to these reasons, the softgel capsules market is expected to rise further.
As manufacturing and research methodologies flourish, cost-effective softgel products are expected to be released by all major manufacturers to garner market share in a very competitive environment. The covid-19 pandemic positively helped the growth of the softgel capsules market by boosting demand for various pharmaceutical and nutraceutical products.
Development efforts for an oral vaccine against covid-19 also generated extensive demand for softgel capsules. Additionally, a general shift toward a healthy lifestyle, coupled with increased formulation compatibility has ensured the growth of the softgel capsules market during the forecast period.
There is strong anticipation for the growth of the softgel capsules market in the North American region during the forecast period. The growing prevalence of chronic diseases, increasing geriatric population, and acknowledgment of the benefits of softgel capsules in the general population will be the primary factors influencing the rapid growth of this sector in North America.
The presence of several companies and organizations involved in the research and development of softgel capsules within this region, especially in the USA is also expected to have a role in the increased growth of the softgel capsules market in this region.
Growing awareness of dosage and formulation compatibility is anticipated to usher novel drug delivery systems utilizing softgel capsules. This along with rising healthcare expenditure, higher disposable income, and favorable reimbursement factors are expected to drive the growth of the softgel capsules market throughout all major regions of the world.
Some of the established players in softgel capsule manufacturing and distribution are Aenova Group GmbH, Catalent Inc., Capsugel (Lonza), Curtis Health Caps, Captek Softgel International Inc., Delpharm Evreux, Fuji capsules Co., Ltd., Guangdong Yichao Biological Co., Ltd., Eurocaps Ltd., Sirio Pharma Co., Procaps Group, Patheon, and Estrellas and many more.
These companies regularly utilize competitive growth strategies like novel product development, cost reductions, collaborations, mergers, etc to achieve higher market share.
By Material
By Application
By Distribution Channels
By Geography
The softgel capsules market is expected grow at a CAGR of 7.5% from 2023 to 2032.
Increased support for the usage of softgel capsules, rising use of softgel capsules in health supplements, rise in consumer acceptance of vegetarian softgel capsules, rising geriatric population, governmental awareness, and expenditure growth, increased e-commerce-based shopping, and established supply lines are together enabling better growth of Softgel Capsules Market across the globe.
The softgel capsules market size was estimated to be US$ 7.5 billion in 2021.
Aenova Group GmbH, Catalent Inc., Capsugel (Lonza), Curtis Health Caps, Captek Softgel International Inc., Delpharm Evreux, Fuji capsules Co., Ltd., Guangdong Yichao Biological Co., Ltd., Eurocaps Ltd., Sirio Pharma Co., Procaps Group, Patheon, and Estrellas along with several others.
There is strong anticipation for the growth of the softgel capsules market in the North American region during the forecast period. The growing prevalence of chronic diseases, increasing geriatric population, and acknowledgment of the benefits of softgel capsules in the general population will be the primary factors influencing the rapid growth of this sector in North America.
The covid-19 pandemic has shown a positive growth on global softgel capsules market due to increased usage of nutraceutical and pharmaceutical therapies and health awareness during this period.
Softgel capsules are a type of capsules that are mainly made from organic consumable substances like gelatin, pullulan, HPMC, potato starch, pectin, etc. Softgel capsules enhance the absorption time of poorly soluble formulations that are present in semi-solid or liquid form.
Copyright © 2025 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved